Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients

Peer Review reports

Original Submission
20 Feb 2003	Submitted	Original manuscript
6 Mar 2003	Reviewed	Reviewer Report - Rolf van Heeswijk
18 Mar 2003	Reviewed	Reviewer Report - Leslie Huson
18 Apr 2003	Author responded	Author comments - Keith Pappa
Resubmission - Version 2
18 Apr 2003	Submitted	Manuscript version 2
29 Apr 2003	Reviewed	Reviewer Report - Leslie Huson
30 Apr 2003	Reviewed	Reviewer Report - Rolf van Heeswijk
16 May 2003	Author responded	Author comments - Keith Pappa
Resubmission - Version 3
16 May 2003	Submitted	Manuscript version 3
Publishing
10 Jun 2003	Editorially accepted
10 Jun 2003	Article published	10.1186/1471-2334-3-10

Back to article page